T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Match Group
MTCH
|
+$3.31B |
| 2 |
Nike
NKE
|
+$2.27B |
| 3 |
FedEx
FDX
|
+$2.24B |
| 4 |
Bank of America
BAC
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.64B |
Top Sells
| 1 |
IAC Inc
IAC
|
+$3.91B |
| 2 |
Fortive
FTV
|
+$2.68B |
| 3 |
Alibaba
BABA
|
+$1.51B |
| 4 |
Linde
LIN
|
+$1.51B |
| 5 |
Willis Towers Watson
WTW
|
+$1.16B |
Sector Composition
| 1 | Technology | 25.65% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.89% |
| 4 | Financials | 11.37% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
iHeartMedia
IHRT
$389M
| $9.71M | ﹤0.01% |
1,196,363
+6,967
| +0.6% | +$56.6K |
|
|
BMY.RT
1302
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $9.67M | ﹤0.01% |
4,298,720
+591,511
| +16% | +$1.33M |
|
|
CNST
1303
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $9.59M | ﹤0.01% |
473,333
+199,294
| +73% | +$4.04M |
|
1304
Hain Celestial
HAIN
$194M
| $9.55M | ﹤0.01% |
278,425
+243,809
| +704% | +$8.36M |
|
1305
Kymera Therapeutics
KYMR
$3.36B
| $9.52M | ﹤0.01% |
+294,695
| New | +$9.52M |
|
1306
iShares Core S&P 500 ETF
IVV
$675B
| $9.49M | ﹤0.01% |
28,245
+3,228
| +13% | +$1.08M |
|
1307
Royal Gold
RGLD
$12.5B
| $9.46M | ﹤0.01% |
78,710
-6,760
| -8% | -$812K |
|
1308
Hamilton Lane
HLNE
$6.53B
| $9.36M | ﹤0.01% |
144,903
+39,581
| +38% | +$2.56M |
|
1309
Orchestra BioMed
OBIO
$139M
| $9.35M | ﹤0.01% |
+850,000
| New | +$9.35M |
|
1310
RenaissanceRe
RNR
$11.6B
| $9.34M | ﹤0.01% |
55,015
-53,503
| -49% | -$9.08M |
|
1311
Globant
GLOB
$2.47B
| $9.31M | ﹤0.01% |
51,935
-2,941
| -5% | -$527K |
|
|
VER
1312
DELISTED
VEREIT, Inc.
VER
| $9.28M | ﹤0.01% |
285,592
-59,249
| -17% | -$1.93M |
|
1313
FRP Holdings
FRPH
$483M
| $9.25M | ﹤0.01% |
444,002
-1,800
| -0.4% | -$37.5K |
|
1314
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.06B
| $9.06M | ﹤0.01% |
+304,600
| New | +$9.06M |
|
1315
Invitation Homes
INVH
$18.5B
| $8.95M | ﹤0.01% |
319,614
-1,083
| -0.3% | -$30.3K |
|
1316
Universal Insurance Holdings
UVE
$719M
| $8.93M | ﹤0.01% |
644,927
-142,842
| -18% | -$1.98M |
|
1317
Lemonade
LMND
$3.88B
| $8.87M | ﹤0.01% |
+178,388
| New | +$8.87M |
|
1318
Kimco Realty
KIM
$15.2B
| $8.86M | ﹤0.01% |
787,032
-7,229
| -0.9% | -$81.4K |
|
1319
ON Semiconductor
ON
$19.7B
| $8.68M | ﹤0.01% |
400,105
-96,128
| -19% | -$2.08M |
|
1320
Markel Group
MKL
$24.7B
| $8.65M | ﹤0.01% |
8,882
-1,235
| -12% | -$1.2M |
|
1321
Ironwood Pharmaceuticals
IRWD
$213M
| $8.64M | ﹤0.01% |
960,158
-64,134
| -6% | -$577K |
|
1322
Pinterest
PINS
$23.8B
| $8.61M | ﹤0.01% |
207,364
-1,222,267
| -85% | -$50.7M |
|
1323
Zions Bancorporation
ZION
$8.62B
| $8.58M | ﹤0.01% |
293,646
-19,198
| -6% | -$561K |
|
1324
Wave Life Sciences
WVE
$1.11B
| $8.49M | ﹤0.01% |
999,918
-319,064
| -24% | -$2.71M |
|
1325
Invesco
IVZ
$10B
| $8.48M | ﹤0.01% |
743,177
+37,271
| +5% | +$425K |
|